<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38947091</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Jun</Month><Day>19</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>A causal link between autoantibodies and neurological symptoms in long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.06.18.24309100</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.06.18.24309100</ELocationID><Abstract><AbstractText>Acute SARS-CoV-2 infection triggers the generation of diverse and functional autoantibodies (AABs), even after mild cases. Persistently elevated autoantibodies have been found in some individuals with long COVID (LC). Using a &gt;21,000 human protein array, we identified diverse AAB targets in LC patients that correlated with their symptoms. Elevated AABs to proteins in the nervous system were found in LC patients with neurocognitive and neurological symptoms. Purified Immunoglobulin G (IgG) samples from these individuals reacted with human pons tissue and were cross-reactive with mouse sciatic nerves, spinal cord, and meninges. Antibody reactivity to sciatic nerves and meninges correlated with patient-reported headache and disorientation. Passive transfer of IgG from patients to mice led to increased sensitivity and pain, mirroring patient-reported symptoms. Similarly, mice injected with IgG showed loss of balance and coordination, reflecting donor-reported dizziness. Our findings suggest that targeting AABs could benefit some LC patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santos Guedes de Sa</LastName><ForeName>Keyla</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-6950-589X</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silva</LastName><ForeName>Julio</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8212-7440</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bayarri-Olmos</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-3202-9679</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brinda</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alec Rath Constable</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colom Diaz</LastName><ForeName>Patricia A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwon</LastName><ForeName>Dong-Il</ForeName><Initials>DI</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodrigues</LastName><ForeName>Gisele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wenxue</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale Cancer Biology Institute, Yale University, West Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhattacharjee</LastName><ForeName>Bornali</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-0801-1543</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Jamie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cohen Center for Recovery from Complex Chronic Illness, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabacof</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6036-2447</Identifier><AffiliationInfo><Affiliation>Cohen Center for Recovery from Complex Chronic Illness, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yansheng</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2626-3912</Identifier><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Yale Cancer Biology Institute, Yale University, West Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putrino</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-2232-3324</Identifier><AffiliationInfo><Affiliation>Cohen Center for Recovery from Complex Chronic Illness, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horvath</LastName><ForeName>Tamas L</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Yale University School of Medicine, New Haven, CT 06520.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwasaki</LastName><ForeName>Akiko</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7824-9856</Identifier><AffiliationInfo><Affiliation>Department of Immunobiology, Yale School of Medicine, Center for Infection and Immunity, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI157488</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoantibodies</Keyword><Keyword MajorTopicYN="N">Chronic Pain</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>Declaration of interests A. I. co-founded RIGImmune, Xanadu Bio and PanV and is a member of the Board of Directors of Roche Holding Ltd and Genentech. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>1</Day><Hour>5</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38947091</ArticleId><ArticleId IdType="pmc">PMC11213106</ArticleId><ArticleId IdType="doi">10.1101/2024.06.18.24309100</ArticleId><ArticleId IdType="pii">2024.06.18.24309100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ford Nd Fau - Slaughter D., Slaughter D Fau - Edwards D., Edwards D Fau - Dalton A., Dalton A Fau - Perrine C., Perrine C Fau - Vahratian A., Vahratian A Fau - Saydah S., and Saydah S. (2023). Long COVID and Significant Activity Limitation Among Adults, by Age - United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb Mortal Wkly Rep 72, 866&#x2013;870. 10.15585/mmwr.mm7232a3.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua M.J., Gonakoti S., Shariff R., Corpuz C., Acosta R.A.H., Chang H., Asemota I., Gobbi E., and Rezai K. (2023). Prevalence and Characteristics of Long COVID 7&#x2013;12 Months After Hospitalization Among Patients From an Urban Safety-Net Hospital: A Pilot Study. AJPM Focus 2, 100091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10036151</ArticleId><ArticleId IdType="pubmed">37131536</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F., Ling S., Lui L.M.W., Lee Y., Gill H., Teopiz K.M., Rodrigues N.B., Subramaniapillai M., Di Vincenzo J.D., Cao B., et al. (2022). Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun 101, 93&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y.A.-O., and Al-Aly Z.A.-O. (2022). Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med 28, 2398&#x2013;2405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D.A.-O., Bosworth M.L., King S., Pouwels K.B., Glickman M., Nafilyan V.A.-O.X., Zaccardi F., Khunti K.A.-O., Alwan N.A.-O., and Walker A.S. (2022). Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. Open Forum Infect Dis 9, ofac464. 10.1093/ofid/ofac464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac464</ArticleId><ArticleId IdType="pmc">PMC9494414</ArticleId><ArticleId IdType="pubmed">36168555</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G.A.-O.X., Lee S., Alfaro-Almagro F., Arthofer C.A.-O., Wang C.A.-O., McCarthy P., Lange F.A.-O., Andersson J.L.R., Griffanti L., Duff E., et al. (2022). SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature 604, 697&#x2013;707. 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham E.A.-O., Clark J.A.-O., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Jia D.T., Balabanov R., Ho S.U., et al. (2021). Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol 8, 1073&#x2013;1085. 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N., Khodayari Y., Hosseinian-Far A., Zarei H., Rasoulpoor S., Akbari H., and Mohammadi M.A.-O. (2022). Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis. Biopsychosoc Med 16, 21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9589726</ArticleId><ArticleId IdType="pubmed">36274177</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A.-O., and Dorri J.A. (2023). ME/CFS and Post-Exertional Malaise among Patients with Long COVID. Neurol Int 15, 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9844405</ArticleId><ArticleId IdType="pubmed">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E.J., Ahn Y.C., Jang E.S., Lee S.W., Lee S.H., and Son C.A.-O. (2020). Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med 18, 100. 10.1186/s12967-020-02269-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. (2015). Mil Med 180, 721&#x2013;723. 10.7205/MILMED-D-15-00085.</Citation><ArticleIdList><ArticleId IdType="doi">10.7205/MILMED-D-15-00085</ArticleId><ArticleId IdType="pubmed">26126237</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Hamdh B., and Nazzal Z.A.-O. (2023). A prospective cohort study assessing the relationship between long-COVID symptom incidence in COVID-19 patients and COVID-19 vaccination. Sci Rep 13, 4896. 10.1038/s41598-023-30583-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-30583-2</ArticleId><ArticleId IdType="pmc">PMC10039348</ArticleId><ArticleId IdType="pubmed">36966161</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. (2022). Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect 28, 611.e619&#x2013;611.e616. 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. (2021). Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283&#x2013;288. 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder J., Lindqvist I., Rasmusson A.J., Hus&#xe9;n E., R&#xf6;nnelid J., Kumlien E., Rostami E., Virhammar J., and Cunningham J.L. (2021). Indirect immunofluorescence for detecting anti-neuronal autoimmunity in CSF after COVID-19 - Possibilities and pitfalls. Brain Behav Immun 94, 473&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9761871</ArticleId><ArticleId IdType="pubmed">33631284</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C., Boesl F., Goereci Y., Gerhard A., Schweitzer F., Schroeder M., Foverskov-Rasmussen H., Heine J., Quitschau A., Kandil F.I., et al. (2023). Association of cerebrospinal fluid brain-binding autoantibodies with cognitive impairment in post-COVID-19 syndrome. Brain Behav Immun 109, 139&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9841734</ArticleId><ArticleId IdType="pubmed">36657623</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C., Ferse C., Kreye J., Reincke S.M., Sanchez-Sendin E., Rocco A., Steinbrenner M., Angermair S., Treskatsch S., Zickler D., et al. (2021). High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain, Behavior, and Immunity 93, 415&#x2013;419. 10.1016/j.bbi.2020.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine L.S., Lifland B., Check J.R., Angarita G.A., Ngo T.T., Chen P., Dandekar R., Alvarenga B.D., Browne W.D., Pleasure S.J., et al. (2023). Anti-SARS-CoV-2 and Autoantibody Profiling of a COVID-19 Patient With Subacute Psychosis Who Remitted After Treatment With Intravenous Immunoglobulin. Biol Psychiatry 93, e25&#x2013;e29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9722219</ArticleId><ArticleId IdType="pubmed">36481066</ArticleId></ArticleIdList></Reference><Reference><Citation>Muri J., Cecchinato V., Cavalli A., Shanbhag A.A., Matkovic M., Biggiogero M., Maida P.A., Moritz J., Toscano C., Ghovehoud E., et al. (2023). Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nature Immunology 24, 604&#x2013;611. 10.1038/s41590-023-01445-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01445-w</ArticleId><ArticleId IdType="pmc">PMC10063443</ArticleId><ArticleId IdType="pubmed">36879067</ArticleId></ArticleIdList></Reference><Reference><Citation>Szewczykowski C., Mardin C., Lucio M., Wallukat G., Hoffmanns J., Schr&#xf6;der T., Raith F., Rogge L., Heltmann F., Moritz M., et al. (2022). Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation. Int J Mol Sci 23, 7209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9266742</ArticleId><ArticleId IdType="pubmed">35806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., H&#xf6;nicke A.S., and M&#xfc;ller J. (2021). Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun 4, 100100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M.A.-O., Ramonell R.P., Haddad N.A.-O., Anam F.A., Rudolph M.A.-O., Walker T.A., Truong A.D., Dixit A.N., Han J.A.-O., Cabrera-Mora M., et al. Dysregulated naive B cells and de novo autoreactivity in severe COVID-19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9630115</ArticleId><ArticleId IdType="pubmed">36044993</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter M.M., Martins T.A., Kulsvehagen L., P&#xf6;ssnecker E., Duchemin W., Hogan S., Sanabria-Diaz G., M&#xfc;ller J., Chiappini A., Rychen J., et al. (2022). Severe Neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nature Communications 13, 6777. 10.1038/s41467-022-34068-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H.A.-O., Szklarski M.A.-O., Lorenz S., Sotzny F., Bauer S., Philippe A., Kedor C., Grabowski P., Lange T.A.-O., Riemekasten G., et al. (2021). Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Clin Med 10, 3675. 10.3390/jcm10163675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10163675</ArticleId><ArticleId IdType="pmc">PMC8397061</ArticleId><ArticleId IdType="pubmed">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabkova V.A.-O., Gavrilova N.Y., Poletaeva A.A., Pukhalenko A.I., Koshkina I.A., Churilov L.A.-O., and Shoenfeld Y. (2023). Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity. Biomedicines 11, 257. 10.3390/biomedicines11020257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11020257</ArticleId><ArticleId IdType="pmc">PMC9952981</ArticleId><ArticleId IdType="pubmed">36830795</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M., Grabowski P., Heidecke H., Bauer S., Hanitsch L.G., Wittke K., Meisel C., Reinke P., Volk H.D., Fluge &#xd8;., et al. (2016). Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav Immun 52, 32&#x2013;39. 10.1016/j.bbi.2015.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.09.013</ArticleId><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra A., Wormser Gp Fau - Klempner M.S., Klempner Ms Fau - Trevino R.P., Trevino Rp Fau - Crow M.K., Crow Mk Fau - Latov N., Latov N Fau - Alaedini A., and Alaedini A. (2010). Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun 24, 1018&#x2013;1024. 10.1016/j.bbi.2010.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.03.002</ArticleId><ArticleId IdType="pmc">PMC2897967</ArticleId><ArticleId IdType="pubmed">20227484</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloupenska K.A.-O., Koubkova B., Horak P.A.-O.X., Hutyrova B., Racansky M., Mares J., Miklusova M., Schovanek J., Zapletalova J., Raska M.A.-O., and Krupka M.A.-O. (2023). Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome. Life (Basel) 13, 527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9964525</ArticleId><ArticleId IdType="pubmed">36836887</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauntt C.J., Arizpe Hm Fau - Higdon A.L., Higdon Al Fau - Wood H.J., Wood Hj Fau - Bowers D.F., Bowers Df Fau - Rozek M.M., Rozek Mm Fau - Crawley R., and Crawley R. (1995). Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis. J Immunol 154, 2983&#x2013;2995.</Citation><ArticleIdList><ArticleId IdType="pubmed">7533190</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz T.A.-O., Brewer R.A.-O., Ho P.A.-O.X., Moon J.A.-O.X., Jude K.A.-O., Fernandez D.A.-O.X., Fernandes R.A., Gomez A.M., Nadj G.S., Bartley C.A.-O., et al. (2022). Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9382663</ArticleId><ArticleId IdType="pubmed">35073561</ArticleId></ArticleIdList></Reference><Reference><Citation>Leis A.A., Szatmary G Fau - Ross M.A., Ross Ma Fau - Stokic D.S., and Stokic D.S. (2014). West nile virus infection and myasthenia gravis. Muscle Nerve 49, 26&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">23559196</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasilevska V., Guest P.C., Bernstein H.G., Schroeter M.L., Geis C., and Steiner J.A.-O. (2021). Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases. J Neuroinflammation 18, 245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8551937</ArticleId><ArticleId IdType="pubmed">34711233</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z.S., Granucci F Fau - Yeh L., Yeh L Fau - Schaffer P.A., Schaffer Pa Fau - Cantor H., and Cantor H. (1998). Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279, 1344&#x2013;1347.</Citation><ArticleIdList><ArticleId IdType="pubmed">9478893</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann D.A., Rose Nr Fau - Ansari A.A., Ansari Aa Fau - Herskowitz A., and Herskowitz A. (1994). Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. J Immunol 152, 343&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">8254202</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Bartley C.M., Chow R.D., Ngo T.T., Jiang R., Zamecnik C.R., Dandekar R., Loudermilk R.P., Dai Y., Liu F., et al. (2021). Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med 2, 100288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091032</ArticleId><ArticleId IdType="pubmed">33969321</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng K., Li X., Yang D., Chan S.C.W., Zhou J., Wan E.Y.F., Chui C.S.L., Lai F.T.T., Wong C.K.H., Chan E.W.Y., et al. (2023). Risk of autoimmune diseases following COVID-19 and the potential protective effect from vaccination: a population-based cohort study. EClinicalMedicine 63, 102154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10458663</ArticleId><ArticleId IdType="pubmed">37637754</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang R., Yen-Ting Chen T., Wang S.I., Hung Y.M., Chen H.Y., and Wei C.J. (2023). Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine 56, 101783. 10.1016/j.eclinm.2022.101783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101783</ArticleId><ArticleId IdType="pmc">PMC9830133</ArticleId><ArticleId IdType="pubmed">36643619</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesch F., Ehm F., Vivirito A., Wende D., Batram M., Loser F., Menzer S., Jacob J., Roessler M., Seifert M., et al. (2023). Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study. Clin Rheumatol 42, 2905&#x2013;2914. 10.1007/s10067-023-06670-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-023-06670-0</ArticleId><ArticleId IdType="pmc">PMC10497688</ArticleId><ArticleId IdType="pubmed">37335408</ArticleId></ArticleIdList></Reference><Reference><Citation>Syed U., Subramanian A., Wraith D.C., Lord J.M., McGee K., Ghokale K., Nirantharakumar K., and Haroon S. (2023). Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care. BMC Med 21, 363. 10.1186/s12916-023-03049-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-03049-5</ArticleId><ArticleId IdType="pmc">PMC10512476</ArticleId><ArticleId IdType="pubmed">37735654</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J.A.-O., Wood J., Jaycox J.R., Dhodapkar R.A.-O., Lu P.A.-O.X., Gehlhausen J.R., Tabachnikova A., Greene K., Tabacof L., Malik A.A., et al. (2023). Distinguishing features of long COVID identified through immune profiling. Nature 623, 139&#x2013;148. 10.1038/s41586-023-06651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06651-y</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C.A.-O., Vogels C.B.F., Yildirim I., Rothman J.A.-O., Lu P.A.-O.X., Monteiro V., Gehlhausen J.R., Campbell M., Silva J.A.-O., Tabachnikova A., et al. (2021). Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity. Nature 600, 523&#x2013;529. 10.1038/s41586-021-04085-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04085-y</ArticleId><ArticleId IdType="pmc">PMC9348899</ArticleId><ArticleId IdType="pubmed">34634791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehnert M., Li W., Wu C., Salovska B., and Liu Y.A.-O. (2019). Combining Rapid Data Independent Acquisition and CRISPR Gene Deletion for Studying Potential Protein Functions: A Case of HMGN1. Proteomics 19, e1800438.</Citation><ArticleIdList><ArticleId IdType="pubmed">30901150</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Ba Q., Lu D., Li W., Salovska B., Hou P., Mueller T., Rosenberger G., Gao E., Di Y., et al. (2021). Global and Site-Specific Effect of Phosphorylation on Protein Turnover. Dev Cell 56, 111&#x2013;124.e116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855865</ArticleId><ArticleId IdType="pubmed">33238149</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruderer R., Bernhardt O.M., Gandhi T., Xuan Y., Sondermann J., Schmidt M., Gomez-Varela D., and Reiter L. (2017). Optimization of Experimental Parameters in Data-Independent Mass Spectrometry Significantly Increases Depth and Reproducibility of Results. Mol Cell Proteomics 16, 2296&#x2013;2309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5724188</ArticleId><ArticleId IdType="pubmed">29070702</ArticleId></ArticleIdList></Reference><Reference><Citation>Facer P., Punjabi Pp Fau - Abrari A., Abrari A Fau - Kaba R.A., Kaba Ra Fau - Severs N.J., Severs Nj Fau - Chambers J., Chambers J Fau - Kooner J.S., Kooner Js Fau - Anand P., and Anand P. (2011). Localisation of SCN10A gene product Na(v)1.8 and novel pain-related ion channels in human heart. Int Heart J 52, 146&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">21646736</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovaguimian A., and Gibbons C.H. (2011). Diagnosis and treatment of pain in small-fiber neuropathy. Curr Pain Headache Rep 15, 193&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3086960</ArticleId><ArticleId IdType="pubmed">21286866</ArticleId></ArticleIdList></Reference><Reference><Citation>Khennouf L., Gesslein B., Brazhe A., Octeau J.C., Kutuzov N., Khakh B.S., and Lauritzen M. (2018). Active role of capillary pericytes during stimulation-induced activity and spreading depolarization. Brain 141, 2032&#x2013;2046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6022680</ArticleId><ArticleId IdType="pubmed">30053174</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano M., Bottin R Fau - Andreoli C., Andreoli C Fau - Marcon M., and Marcon M. (1995). Tinnitus as a Presenting Symptom in Secondary Neuropathy: a Case Report. Int Tinnitus J 1, 153&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">10753336</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandan H.S., Prabhu P., and Deepthi M. (2013). Prevalence and characteristics of tinnitus in individuals with auditory neuropathy spectrum disorder. Hearing, Balance and Communication 11, 214&#x2013;217. 10.3109/21695717.2013.821755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21695717.2013.821755</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasilkov V., Caswell-Midwinter B., Zhao Y., de Gruttola V., Jung D.H., Liberman M.C., and Maison S.F. (2023). Evidence of cochlear neural degeneration in normal-hearing subjects with tinnitus. Sci Rep 13, 19870. 10.1038/s41598-023-46741-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-46741-5</ArticleId><ArticleId IdType="pmc">PMC10689483</ArticleId><ArticleId IdType="pubmed">38036538</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M.A.-O., Blish C.A.-O., Sallusto F.A.-O., and Iwasaki A.A.-O. (2022). The immunology and immunopathology of COVID-19. 375, 1122&#x2013;1127.</Citation><ArticleIdList><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Vodopiutz J., Schmook Mt Fau - Konstantopoulou V., Konstantopoulou V Fau - Plecko B., Plecko B Fau - Greber-Platzer S., Greber-Platzer S Fau - Creus M., Creus M Fau - Seidl R., Seidl R Fau - Janecke A.R., and Janecke A.R. (2015). MED20 mutation associated with infantile basal ganglia degeneration and brain atrophy. Eur J Pediatr 174, 113&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">25446406</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiano C., Luongo L., Maione S., and Napoli C. (2023). Mediator complex in neurological disease. Life Sci 329, 121986.</Citation><ArticleIdList><ArticleId IdType="pubmed">37516429</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Caballero A., Gadotti V.M., Stemkowski P., Weiss N., Souza I.A., Hodgkinson V., Bladen C., Chen L., Hamid J., Pizzoccaro A., et al. (2014). The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity. Neuron 83, 1144&#x2013;1158.</Citation><ArticleIdList><ArticleId IdType="pubmed">25189210</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmerjahn F., and Ravetch J.V. (2008). Anti-inflammatory actions of intravenous immunoglobulin. Annu Rev Immunol 26, 513&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">18370923</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganotti P., Garascia G., Furlanis G., and Buoite Stella A. (2023). Efficacy of intravenous immunoglobulin (IVIg) on COVID-19-related neurological disorders over the last 2 years: an up-to-date narrative review. Front Neurosci. 17, 1159929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10166837</ArticleId><ArticleId IdType="pubmed">37179564</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlpine L.A.-O., Zubair A.A.-O., Joseph P.A.-O., and Spudich S. (2024). Case-Control Study of Individuals With Small Fiber Neuropathy After COVID-19. Neurol Neuroimmunol Neuroinflamm 11, e200244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11087026</ArticleId><ArticleId IdType="pubmed">38630952</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>